
Nephros Inc (NEPH) Stock Forecast & Price Target
Nephros Inc (NEPH) Analyst Ratings
Bulls say
Nephros Inc. is forecasted to experience revenue growth, with anticipated revenues of $3.6 million in 4Q24, representing a 12% increase from the previous year, alongside a reduced net loss per share, indicating improved financial health. The company has successfully maintained overhead expenses while enhancing its gross margins to 61.9% in 1Q24, which reflects operational efficiency and effective cost management. Additionally, recurring revenue growth and a rebound in emergency response orders have contributed to a significant improvement in adjusted EBITDA, highlighting strong performance in its core markets and a favorable outlook for future profitability.
Bears say
Nephros Inc. is projected to experience a 2% decline in revenue for full-year 2024, totaling $13.9 million, while still reporting a reduced net loss compared to the previous year. The company's cash reserves have diminished significantly from $4.3 million at the beginning of the year to $3.6 million by the end of the first quarter, primarily due to increased inventory costs and early bonus payments. Additionally, Nephros' valuation of 1.2X estimated 2024 revenues is substantially lower than that of its industry peers, which trade at ratios of 3X-4X, indicating potential undervaluation or lack of market confidence in the company's growth prospects.
This aggregate rating is based on analysts' research of Nephros Inc and is not a guaranteed prediction by Public.com or investment advice.
Nephros Inc (NEPH) Analyst Forecast & Price Prediction
Start investing in Nephros Inc (NEPH)
Order type
Buy in
Order amount
Est. shares
0 shares